Differential iridoid production as revealed by a diversity panel of 84 cultivated and wild blueberry species

Courtney P. Leisner, Mohamed O. Kamileen, Megan E. Conway, Sarah E. O'Connor, C. Robin Buell

    Research output: Contribution to journalArticle

    • 1 Citations

    Abstract

    Cultivated blueberry (Vaccinium corymbosum, Vaccinium angustifolium, Vaccinium darrowii, and Vaccinium virgatum) is an economically important fruit crop native to North America and a member of the Ericaceae family. Several species in the Ericaceae family including cranberry, lignonberry, bilberry, and neotropical blueberry species have been shown to produce iridoids, a class of pharmacologically important compounds present in over 15 plant families demonstrated to have a wide range of biological activities in humans including anticancer, anti-bacterial, and anti-inflammatory. While the antioxidant capacity of cultivated blueberry has been well studied, surveys of iridoid production in blueberry have been restricted to fruit of a very limited number of accessions of V. corymbosum, V. angustifolium and V. virgatum; none of these analyses have detected iridoids. To provide a broader survey of iridoid biosynthesis in cultivated blueberry, we constructed a panel of 84 accessions representing a wide range of cultivated market classes, as well as wild blueberry species, and surveyed these for the presence of iridoids. We identified the iridoid glycoside monotropein in fruits and leaves of all 13 wild Vaccinium species, yet only five of the 71 cultivars. Monotropein positive cultivars all had recent introgressions from wild species, suggesting that iridoid production can be targeted through breeding efforts that incorporate wild germplasm. A series of diverse developmental tissues was also surveyed in the diversity panel, demonstrating a wide range in iridoid content across tissues. Taken together, this data provides the foundation to dissect the molecular and genetic basis of iridoid production in blueberry.

    Original languageEnglish (US)
    Article number0179417
    JournalPLoS ONE
    Volume12
    Issue number6
    DOIs
    StatePublished - Jun 1 2017

    Profile

    blueberries
    Blueberry Plant
    Hypocalcemia
    Vaccinium
    Library Catalogs
    Echoencephalography
    Iridoids
    Fruit
    iridoids
    Ericaceae
    Vaccinium virgatum
    Vaccinium angustifolium
    Vaccinium corymbosum
    fruits
    cultivars
    Biosynthesis
    Bioactivity
    Crops
    Atrophy
    Vaccinium myrtillus

    ASJC Scopus subject areas

    • Medicine(all)
    • Biochemistry, Genetics and Molecular Biology(all)
    • Agricultural and Biological Sciences(all)

    Cite this

    Differential iridoid production as revealed by a diversity panel of 84 cultivated and wild blueberry species. / Leisner, Courtney P.; Kamileen, Mohamed O.; Conway, Megan E.; O'Connor, Sarah E.; Buell, C. Robin.

    In: PLoS ONE, Vol. 12, No. 6, 0179417, 01.06.2017.

    Research output: Contribution to journalArticle

    Leisner, Courtney P.; Kamileen, Mohamed O.; Conway, Megan E.; O'Connor, Sarah E.; Buell, C. Robin / Differential iridoid production as revealed by a diversity panel of 84 cultivated and wild blueberry species.

    In: PLoS ONE, Vol. 12, No. 6, 0179417, 01.06.2017.

    Research output: Contribution to journalArticle

    @article{cc3199e442984d76a0c89efa812b3672,
    title = "Differential iridoid production as revealed by a diversity panel of 84 cultivated and wild blueberry species",
    abstract = "Cultivated blueberry (Vaccinium corymbosum, Vaccinium angustifolium, Vaccinium darrowii, and Vaccinium virgatum) is an economically important fruit crop native to North America and a member of the Ericaceae family. Several species in the Ericaceae family including cranberry, lignonberry, bilberry, and neotropical blueberry species have been shown to produce iridoids, a class of pharmacologically important compounds present in over 15 plant families demonstrated to have a wide range of biological activities in humans including anticancer, anti-bacterial, and anti-inflammatory. While the antioxidant capacity of cultivated blueberry has been well studied, surveys of iridoid production in blueberry have been restricted to fruit of a very limited number of accessions of V. corymbosum, V. angustifolium and V. virgatum; none of these analyses have detected iridoids. To provide a broader survey of iridoid biosynthesis in cultivated blueberry, we constructed a panel of 84 accessions representing a wide range of cultivated market classes, as well as wild blueberry species, and surveyed these for the presence of iridoids. We identified the iridoid glycoside monotropein in fruits and leaves of all 13 wild Vaccinium species, yet only five of the 71 cultivars. Monotropein positive cultivars all had recent introgressions from wild species, suggesting that iridoid production can be targeted through breeding efforts that incorporate wild germplasm. A series of diverse developmental tissues was also surveyed in the diversity panel, demonstrating a wide range in iridoid content across tissues. Taken together, this data provides the foundation to dissect the molecular and genetic basis of iridoid production in blueberry.",
    author = "Leisner, {Courtney P.} and Kamileen, {Mohamed O.} and Conway, {Megan E.} and O'Connor, {Sarah E.} and Buell, {C. Robin}",
    year = "2017",
    month = "6",
    doi = "10.1371/journal.pone.0179417",
    volume = "12",
    journal = "PLoS One",
    issn = "1932-6203",
    publisher = "Public Library of Science",
    number = "6",

    }

    TY - JOUR

    T1 - Differential iridoid production as revealed by a diversity panel of 84 cultivated and wild blueberry species

    AU - Leisner,Courtney P.

    AU - Kamileen,Mohamed O.

    AU - Conway,Megan E.

    AU - O'Connor,Sarah E.

    AU - Buell,C. Robin

    PY - 2017/6/1

    Y1 - 2017/6/1

    N2 - Cultivated blueberry (Vaccinium corymbosum, Vaccinium angustifolium, Vaccinium darrowii, and Vaccinium virgatum) is an economically important fruit crop native to North America and a member of the Ericaceae family. Several species in the Ericaceae family including cranberry, lignonberry, bilberry, and neotropical blueberry species have been shown to produce iridoids, a class of pharmacologically important compounds present in over 15 plant families demonstrated to have a wide range of biological activities in humans including anticancer, anti-bacterial, and anti-inflammatory. While the antioxidant capacity of cultivated blueberry has been well studied, surveys of iridoid production in blueberry have been restricted to fruit of a very limited number of accessions of V. corymbosum, V. angustifolium and V. virgatum; none of these analyses have detected iridoids. To provide a broader survey of iridoid biosynthesis in cultivated blueberry, we constructed a panel of 84 accessions representing a wide range of cultivated market classes, as well as wild blueberry species, and surveyed these for the presence of iridoids. We identified the iridoid glycoside monotropein in fruits and leaves of all 13 wild Vaccinium species, yet only five of the 71 cultivars. Monotropein positive cultivars all had recent introgressions from wild species, suggesting that iridoid production can be targeted through breeding efforts that incorporate wild germplasm. A series of diverse developmental tissues was also surveyed in the diversity panel, demonstrating a wide range in iridoid content across tissues. Taken together, this data provides the foundation to dissect the molecular and genetic basis of iridoid production in blueberry.

    AB - Cultivated blueberry (Vaccinium corymbosum, Vaccinium angustifolium, Vaccinium darrowii, and Vaccinium virgatum) is an economically important fruit crop native to North America and a member of the Ericaceae family. Several species in the Ericaceae family including cranberry, lignonberry, bilberry, and neotropical blueberry species have been shown to produce iridoids, a class of pharmacologically important compounds present in over 15 plant families demonstrated to have a wide range of biological activities in humans including anticancer, anti-bacterial, and anti-inflammatory. While the antioxidant capacity of cultivated blueberry has been well studied, surveys of iridoid production in blueberry have been restricted to fruit of a very limited number of accessions of V. corymbosum, V. angustifolium and V. virgatum; none of these analyses have detected iridoids. To provide a broader survey of iridoid biosynthesis in cultivated blueberry, we constructed a panel of 84 accessions representing a wide range of cultivated market classes, as well as wild blueberry species, and surveyed these for the presence of iridoids. We identified the iridoid glycoside monotropein in fruits and leaves of all 13 wild Vaccinium species, yet only five of the 71 cultivars. Monotropein positive cultivars all had recent introgressions from wild species, suggesting that iridoid production can be targeted through breeding efforts that incorporate wild germplasm. A series of diverse developmental tissues was also surveyed in the diversity panel, demonstrating a wide range in iridoid content across tissues. Taken together, this data provides the foundation to dissect the molecular and genetic basis of iridoid production in blueberry.

    UR - http://www.scopus.com/inward/record.url?scp=85020692473&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85020692473&partnerID=8YFLogxK

    U2 - 10.1371/journal.pone.0179417

    DO - 10.1371/journal.pone.0179417

    M3 - Article

    VL - 12

    JO - PLoS One

    T2 - PLoS One

    JF - PLoS One

    SN - 1932-6203

    IS - 6

    M1 - 0179417

    ER -